Host defense peptides in wound healing
- PMID: 18385817
- PMCID: PMC2277318
- DOI: 10.2119/2008-00002.Steinstraesser
Host defense peptides in wound healing
Abstract
Host defense peptides are effector molecules of the innate immune system. They show broad antimicrobial action against gram-positive and -negative bacteria, and they likely play a key role in activating and mediating the innate as well as adaptive immune response in infection and inflammation. These features make them of high interest for wound healing research. Non-healing and infected wounds are a major problem in patient care and health care spending. Increasing infection rates, growing bacterial resistance to common antibiotics, and the lack of effective therapeutic options for the treatment of problematic wounds emphasize the need for new approaches in therapy and pathophysiologic understanding. This review focuses on the current knowledge of host defense peptides affecting wound healing and infection. We discuss the current data and highlight the potential future developments in this field of research.
References
-
- Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis. 2005;5:501–13. - PubMed
-
- Wilson MA. Skin and soft-tissue infections: impact of resistant gram-positive bacteria. Am J Surg. 2003;186:35S–41S. 42S–3S, 61S–4S. - PubMed
-
- Kalorama-Informations. Woundcare Markets, Volume I: Chronic Ulcers. Kalorama Informations, a Division of MarketResearch.com. 2002.
-
- Rice LB. Do we really need new anti-infective drugs? Curr Opin Pharmacol. 2003;3:459–63. - PubMed
-
- Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874–85. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
